Sponsored by: Investment Center

Something new in your business?  Click here to submit your business press release

Chamber Corner | Main Street News | Job Hunt | Classifieds | Calendar | Illinois Lottery 

J&J's profit beats estimates on sales of new drugs

[January 20, 2015]  (Reuters) - Johnson & Johnson reported a slightly better-than-expected quarterly profit as surging sales of new drugs and mainstay older brands offset weak demand for medical devices and consumer healthcare products.

The company's earnings fell to $2.52 billion, or 89 cents per share, in the fourth quarter from $3.52 billion, or $1.23 per share, a year earlier.

Excluding items, J&J earned $1.27 per share.

Total sales fell 0.6 percent to $18.25 billion.

Analysts on average had expected a profit of $1.26 per share and sales of $18.55 billion, according to Thomson Reuters I/B/E/S.

(Reporting by Ransdell Pierson and Vidya L Nathan; Editing by Kirti Pandey)

[© 2014 Thomson Reuters. All rights reserved.]

Copyright 2014 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.